Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bladder cancer
bladder cancer
FDA says Tecentriq won't lose its bladder cancer nod despite phase 3 failure, Roche reports
Fierce Pharma
Tue, 09/12/17 - 10:00 pm
FDA
Tecentriq
Roche
bladder cancer
clinical trials
ESMO: Merck's Keytruda extends survival edge on its bladder cancer rivals
Fierce Pharma
Mon, 09/11/17 - 09:09 am
ESMO
Merck
Keytruda
bladder cancer
ASCO17: Merck touts Keytruda bladder benefit post Tecentriq failure
BioPharma Dive
Mon, 06/5/17 - 12:13 pm
Merck
Keytruda
bladder cancer
Tecentriq
ASCO 2017
Has Merck Lucked Into A $10 Billion Drug?
Forbes
Thu, 05/11/17 - 11:20 am
Merck
Keytruda
bladder cancer
non-small cell lung cancer
In a stunning setback, Roche says its top cancer drug Tecentriq failed a key PhIII study
Endpoints
Wed, 05/10/17 - 10:13 am
Roche
Tecentriq
clinical trials
bladder cancer
Move over, AstraZeneca. Pfizer and Merck KGaA are the newest bladder cancer drugmakers in town
Fierce Pharma
Wed, 05/10/17 - 09:31 am
Pfizer
Merck KGaA
AstraZeneca
Bavencio
avelumab
bladder cancer
Imfinzi
FDA
Opdivo
Tecentriq
AstraZeneca's New Drug: Too Little, Too Late?
Seeking Alpha
Mon, 05/8/17 - 09:51 pm
AstraZeneca
Imfinzi
bladder cancer
Roche's Tecentriq wins FDA OK as first-line treatment in bladder cancer
Fierce Pharma
Tue, 04/18/17 - 09:00 pm
Roche
Tecentriq
bladder cancer
FDA
Merck KGaA, Pfizer get priority review for bladder cancer drug
Yahoo/Reuters
Tue, 02/28/17 - 10:22 am
Merck KGaA
Pfizer
bladder cancer
avelumab
Checkpoint inhibitors set to face off in bladder cancer
BioPharma Dive
Wed, 02/8/17 - 09:48 am
bladder cancer
Bristol-Myers Squibb
Opdivo
Merck
Keytruda
Roche
Tecentriq
AstraZeneca
durvalumab
FDA approves Bristol-Myers' Opdivo for bladder cancer
Yahoo/Reuters
Fri, 02/3/17 - 10:13 am
FDA
Bristol-Myers Squibb
Opdivo
bladder cancer
Taris Biomedical closes enrollment in phase Ib trial for drug-device combo
Mass Device
Sat, 01/7/17 - 12:07 pm
Taris
drug-device combos
devices
gemcitabine
bladder cancer
Your attention, please: AstraZeneca asks for a moment of rapt silence, for a BLA acceptance?
Endpoints
Sun, 12/11/16 - 11:57 am
AstraZeneca
durvalumab
anti-PD-L1
bladder cancer
Heat Biologics stock active on heels of lung, bladder cancer results
Bizjournals.com
Tue, 12/6/16 - 10:07 pm
Heat Biologics
lung cancer
bladder cancer
HS-110
vaccines
Bristol’s Opdivo Has One Eye on Advanced Bladder Cancer
Market Realist
Tue, 11/22/16 - 11:29 am
Bristol-Myers Squibb
Opdivo
bladder cancer
Sanofi Shuts Down Bladder Cancer Drug Production: Inevitable Drug Shortage To Harm Patients
Forbes
Sat, 11/19/16 - 11:25 am
Sanofi
bladder cancer
drug shortages
BCG
Merck's Keytruda succeeds in key bladder cancer trial
Yahoo/Reuters
Fri, 10/21/16 - 09:58 am
Merck
Keytruda
bladder cancer
clinical trials
Merck's Keytruda posts 24% response rate in PhII bladder cancer study
Fierce Pharma
Mon, 10/10/16 - 09:09 am
Merck
Keytruda
bladder cancer
Bristol-Myers Squibb Co Wins a Sixth Breakthrough Tag for Opdivo
Bidness, ETC
Tue, 06/28/16 - 05:23 pm
Bristol-Myers Squibb
Opdivo
breakthrough therapies
bladder cancer
FDA
Bristol-Myers Squibb's bladder cancer treatment granted breakthrough therapy designation
Marketwatch
Mon, 06/27/16 - 10:28 am
Bristol-Myers Squibb
bladder cancer
breakthrough therapies
FDA
Opdivo
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
next ›
last »